Synthon is a Dutch pharmaceutical company which develops and manufactures generic human medicines. Expanding its business activities, Synthon is also engaged in the research and development of biotechnology-based medicines.
Synthon’s head office is in Nijmegen, the Netherlands, and the company has affiliates in nine countries abroad. The company employs around 1.400 staff of whom over 380 are based in Nijmegen.
Synthon products are licensed out to third parties and are marketed worldwide.
The company culture is characterized by a determined and entrepreneurial spirit.
Global Strategic Portfolio Management is key in Synthon’s selection process for new pharmaceuticals. The department is also responsible for the strategic planning process and for business reviews of the pipeline products.
